Hanneke W.M. van Laarhoven

Research interests

Publications

• Gastric cancer

  The Lancet · 2025 · https://doi.org/10.1016/s0140-6736(25)00052-2

• Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise—Evidence and Implications

  Cancer Discovery · 2023 · 10.1158/2159-8290.cd-22-1038

• Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

  Clinical Cancer Research · 2021 · https://doi.org/10.1158/1078-0432.ccr-20-4443

• Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial

  Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.01540

• MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma

  Cancer Treatment Reviews · 2020 · 10.1016/j.ctrv.2020.102024

• White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer

  Nature Communications · 2020 · https://doi.org/10.1038/s41467-020-14310-3

• Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective

  European Journal of Cancer · 2020 · 10.1016/j.ejca.2020.06.019

• Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma

  Proceedings of the National Academy of Sciences · 2019 · 10.1073/pnas.1820459116

• Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial

  ˜The œLancet. Gastroenterology & hepatology · 2019 · https://doi.org/10.1016/s2468-1253(19)30004-4

• Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

  The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(18)30791-5

• Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma

  European Journal of Cancer · 2019 · 10.1016/j.ejca.2019.11.002

• Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

  The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30132-3

• CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

  BMC Cancer · 2018 · 10.1186/s12885-018-4770-2

• Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

  The Lancet Oncology · 2018 · 10.1016/s1470-2045(18)30201-8

• The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength

  Journal of Psychosomatic Research · 2017 · https://doi.org/10.1016/j.jpsychores.2017.05.007

• Weight change during chemotherapy in breast cancer patients: a meta-analysis

  BMC Cancer · 2017 · 10.1186/s12885-017-3242-4

• Clinical and biological effects of demethylating agents on solid tumours – A systematic review

  Cancer Treatment Reviews · 2017 · 10.1016/j.ctrv.2017.01.004

• Measurement Properties of Instruments for Measuring of Lymphedema: Systematic Review

  Physical Therapy · 2016 · 10.2522/ptj.20150412

• Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

  The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00040-6

• Treatment Related Impairments in Arm and Shoulder in Patients with Breast Cancer: A Systematic Review

  PLoS ONE · 2014 · https://doi.org/10.1371/journal.pone.0096748

• The Cancer Worry Scale

  Cancer Nursing · 2013 · https://doi.org/10.1097/ncc.0b013e3182813a17

• Triple‐negative breast cancer: Present challenges and new perspectives

  Molecular Oncology · 2010 · https://doi.org/10.1016/j.molonc.2010.04.006

• Beyond RECIST: Molecular and functional imaging techniques for evaluation of response to targeted therapy

  Cancer Treatment Reviews · 2009 · 10.1016/j.ctrv.2008.12.001

• Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review

  Journal of Nuclear Medicine · 2009 · https://doi.org/10.2967/jnumed.108.057224

• Artificial reporter gene providing MRI contrast based on proton exchange

  Nature Biotechnology · 2007 · https://doi.org/10.1038/nbt1277

Current projects

No projects listed.